ABBOTINDIA — Abbott India Share Price
0.000.00%
Last trade - 00:00- IN₹631.21bn
- IN₹612.96bn
- IN₹58.49bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 40.03 | ||
| PEG Ratio (f) | 3.47 | ||
| EPS Growth (f) | 13.04% | ||
| Dividend Yield (f) | 1.51% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 17.93 | ||
| Price to Tang. Book | 17.97 | ||
| Price to Free Cashflow | 65.33 | ||
| Price to Sales | 10.11 | ||
| EV to EBITDA | 38.42 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 41.4% | ||
| Return on Equity | 40.26% | ||
| Operating Margin | 24.4% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 40,931.44 | 43,100.2 | 49,192.7 | 53,487.3 | 58,489.1 | 63,701.67 | 70,801.75 | 9.72% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +33.59 | +16.44 | +15.61 | +18.84 | +26.54 | +16.13 | +13.04 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Abbott India Limited is an India-based company engaged in the pharmaceuticals business. The Company is involved in product development, manufacturing, and sales of healthcare products. It operates in a single reportable business segment, which is Pharmaceuticals. It distributes products and solutions in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders, Central Nervous System, Vaccines, Multi-Specialty, and primary care. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), and Duvadilan (preterm labor). It offers various products under brands such as Similac, PediaSure, Pedialyte, EleCare, Ensure, and Glucerna.
Directors
- Munir Ahmed Shaikh NEC (73)
- Rajiv Sonalker CFO
- Krupa Anandpara CCO
- Ambati Venu VPR
- Vishwanath Swarup DSL
- Purnajit Gupta DHR
- Rashmi Hegde OTH
- Rumy Kanga OTH
- Mahadeo Karnik OTH
- Sandeep Khandelwal OTH
- Ashok Nair OTH
- Ramanathan V. OTH
- Nagesh Voleti OTH
- Sabina Ewing NED
- Kaiyomarz Marfatia NED
- Sudarshan Jain IND
- Shalini Kamath IND
- Anisha Motwani IND (58)
- Rajendra Shah NID (89)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 22nd, 1944
- Public Since
- November 3rd, 1994
- No. of Shareholders
- 69,382
- No. of Employees
- 3,814
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 21,249,302
- Address
- 3-4 Corporate Park, MUMBAI, 400051
- Web
- https://www.abbott.co.in/
- Phone
- +91 2250461000
- Auditors
- S R B C & CO LLP
Upcoming Events for ABBOTINDIA
Q1 2026 Abbott India Ltd Earnings Release
Abbott India Ltd Annual Shareholders Meeting
Similar to ABBOTINDIA
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
Ajanta Pharma
National Stock Exchange of India
FAQ
What is the Abbott India share price?
As of Today at 19:00 UTC, shares in Abbott India are trading at IN₹29,705.00. This share price information is delayed by 15 minutes.
How has the Abbott India share price performed this year?
Shares in Abbott India last closed at IN₹29,705.00 and the price had moved by +15.7% over the past 365 days. In terms of relative price strength the Abbott India share price has outperformed the S&P BSE 100 Index by +8.99% over the past year.
What are the analyst and broker recommendations for Abbott India?
The overall consensus recommendation for Abbott India is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Abbott India dividend yield?
The Abbott India dividend yield is 1.38% based on the trailing twelve month period.
Does Abbott India pay a dividend?
Last year, Abbott India paid a total dividend of IN₹410.00, and it currently has a trailing dividend yield of 1.38%. We do not have any data on when Abbott India is to next pay dividends.
When does Abbott India next pay dividends?
We do not have data on when Abbott India is to next pay dividends. The historic dividend yield on Abbott India shares is currently 1.38%.
How do I buy Abbott India shares?
To buy shares in Abbott India you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Abbott India?
As of the previous close price of IN₹29,705.00, shares in Abbott India had a market capitalisation of IN₹631.21bn.
Where are Abbott India shares listed?
Here are the trading details for Abbott India:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ABBOTINDIA
What kind of share is Abbott India?
Based on an overall assessment of its quality, value and momentum Abbott India is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Abbott India share price forecast for 2025?
The analyst consensus target price for shares in Abbott India is IN₹33,264.40. That is 11.98% above the last closing price of IN₹29,705.00.
Analysts covering Abbott India currently have a consensus Earnings Per Share (EPS) forecast of IN₹656.44 for the next financial year.
Find out moreWhat is the trend in the Abbott India share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abbott India. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +6.4%.
As of the last closing price of IN₹29,705.00, shares in Abbott India were trading +3.08% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Abbott India PE Ratio?
The Abbott India PE ratio based on its reported earnings over the past 12 months is 40.03. The shares last closed at IN₹29,705.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Abbott India?
Abbott India's management team is headed by:
- Munir Ahmed Shaikh - NEC
- Rajiv Sonalker - CFO
- Krupa Anandpara - CCO
- Ambati Venu - VPR
- Vishwanath Swarup - DSL
- Purnajit Gupta - DHR
- Rashmi Hegde - OTH
- Rumy Kanga - OTH
- Mahadeo Karnik - OTH
- Sandeep Khandelwal - OTH
- Ashok Nair - OTH
- Ramanathan V. - OTH
- Nagesh Voleti - OTH
- Sabina Ewing - NED
- Kaiyomarz Marfatia - NED
- Sudarshan Jain - IND
- Shalini Kamath - IND
- Anisha Motwani - IND
- Rajendra Shah - NID